Gastrointestinal side effects of the non-peptide GLP-1 receptor agonists: A systematic review and meta-analysis
Gastrointestinal side effects of the non-peptide GLP-1 receptor agonists were widely reported but less frequent compared to placebo/ standard treatment. There was no significant dose-dependent increase in the side effects of these medications.
Authors
- Madhur Bhattarai (ORCID: https://orcid.org/0000-0001-6382-1082)
- Krishna Dahal (ORCID: https://orcid.org/0000-0002-4137-1022)
- Himal Bikram Bhattarai (ORCID: https://orcid.org/0000-0001-7523-8038)
- Amit Khanal (ORCID: https://orcid.org/0000-0003-1308-6547)
- Ranjit Sah
- Bibhusan Basnet (ORCID: https://orcid.org/0000-0002-3948-831X)
- Bibek Karki (ORCID: https://orcid.org/0000-0003-0578-9250)
- Philip McDonald
- Basanta Sharma Paudel
- Amit Bhandari
- Sandesh Raman Parajuli
- Sangam Shah
- Khalid Ahmed
- Bidisha Baral
Institutions
- Saint Agnes Hospital (US)
- Reading Hospital (US)
- Hurley Medical Center (US)
- Dubai Hospital (AE)
- Dr. D. Y. Patil Medical College, Hospital and Research Centre (IN)
- UPMC Health System (US)
- Dr. D.Y. Patil Vidyapeeth, Pune (IN)
- Tribhuvan University Teaching Hospital (NP)
- Regional Medical Center (US)
- St. John's Hospital (US)
- Wake Forest University (US)
Publication Details
- Journal
- Medicine
- Published
- 2025-12-26
- DOI
- https://doi.org/10.1097/md.0000000000046671
- Citations
- 1
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 1.29